Back to top
more

Aetna Inc. (AET)

(Delayed Data from NYSE)

$212.70 USD

212.70
NA

+0.70 (0.33%)

Updated Nov 28, 2018 04:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Wellcare Health's (WCG) Inorganic Growth Boosts Revenues

by Zacks Equity Research

Wellcare Health's (WCG) solid top line grows on strategic acquisitions and alliances. Its strong financial health also bodes well for long-term growth.

    Megan Sanks headshot

    Apple in Talks with Aetna to Bring Apple Watch to Millions of Customers

    by Megan Sanks

    Apple (AAPL) and insurance company Aetna (AET) held a series of talks last week to discuss terms of giving the Apple Watch for free or at a discounted rate to Aetna's 23 million customers.

      Aetna's (AET) $1 Billion Notes Due 2047 Rated By A.M Best

      by Zacks Equity Research

      Rating Giant A.M Bests assigned a Long-Term Issue Credit Rating of "bbb" to Aetna's (AET) $1 billion, 3.875% senior notes due to mature on Aug 15, 2047.

        Envision Healthcare (EVHC) Q2 Earnings Beat, '17 View Cut

        by Zacks Equity Research

        Envision Healthcare's (EVHC) strong second-quarter earnings were driven by revenue growth in the Physician Services segment, partly offset by an increase in operating expenses.

          Select Medical (SEM) Q2 Earnings Top Estimates, Revises View

          by Zacks Equity Research

          Select Medical's (SEM) solid Q2 results were driven by the strong performance of all segments.

            WellCare Health (WCG) Beats on Q2 Earnings and Revenues

            by Zacks Equity Research

            Wellcare Health (WCG) reported strong results in the second quarter supported by solid performance across its all three business lines and the acquisitions of Universal American and Care1st Arizona

              Cigna (CI) Earnings Beat in Q2, Guidance Raised, Shares Gain

              by Zacks Equity Research

              Higher revenues, strength in its Global HealthCare segment and membership growth drive an earnings beat at Cigna (CI) in Q2.

                All Eyes On Q2 Earnings And Jobless Claims

                by Zacks Equity Research

                All Eyes On Q2 Earnings And Jobless Claims

                  Mark Vickery headshot

                  More Q2 Earnings Highlights, Plus New Jobless Claims

                  by Mark Vickery

                  Another big morning for Q2 earnings posts, with mostly positive results: Clorox, Yum! and Aetna all surpassed expectations. Avon, however, has hit the skids.

                    Aetna (AET) Tops Q2 Earnings, Revenues, Raises 2017 Guidance

                    by Zacks Equity Research

                    Aetna's (AET) strong second-quarter 2017 results were largely driven by improved expense ratio.

                      Aetna (AET) Q2 Earnings, Revenues Beat Estimates

                      by Zacks Equity Research

                      Aetna beats on earnings. Our consensus called for EPS of $2.34 and the company reported earnings per share of $3.42 and increased 46% year over year

                        Will Loss on Public Exchanges Mar Aetna's (AET) Q2 Earnings?

                        by Zacks Equity Research

                        Aetna's (AET) second-quarter earnings are expected to gain from strong government share buyback. Loss on exchanges will likely be a drag.

                          What's in the Cards for Humana (HUM) this Earnings Season?

                          by Zacks Equity Research

                          Humana's (HUM) second-quarter earnings are likely to be driven by Medicare membership growth.

                            Centene & Unit Inks New Deal to Expand Foothold in Ferguson

                            by Zacks Equity Research

                            Centene & its subsidiary, Home State Health entered into an agreement with Schnuck Markets and the Betty Jean Kerr People's Health Centers to boost Foothold in Ferguson

                              Arpita Dutt headshot

                              Healthcare Stocks in Focus on Latest CBO Report

                              by Arpita Dutt

                              What will the impact be on insurance stocks like Aetna (AET) and hospital stocks if Obamacare is repealed without an immediate replacement?

                                UnitedHealth Faces Moody's Rating Action, Outlook Upgraded

                                by Zacks Equity Research

                                UnitedHealth (UNH) rating action by Moody's takes into account the company's its leadership position in the industry, its diversified business product profile.

                                  Sweta Killa headshot

                                  5 Market-Beating Dividend Stocks for Steady Growth

                                  by Sweta Killa

                                  Though the stock market are at all-time highs, geopolitics, Washington turmoil, and Fed's dovish views make dividend investing a perfect choice.

                                    Cigna (CI) Hits 52-Week High on Recent Buyout, Growth Plans

                                    by Zacks Equity Research

                                    The stock of Cigna (CI) hit a 52-week high of $173.44. The rise in the stock is believed to have been driven by an acquisition, its detailed long-term growth plans.

                                      Cigna Buys Zurich Insurance to Expand in UAE, Shares Gain

                                      by Zacks Equity Research

                                      Cigna Corp. (CI) has acquired Zurich Insurance Middle East. The deal which was completed last month will provide Cigna a stronger foothold in the Gulf countries.

                                        Buy 5 Low-Beta Stocks to Offset Market Volatility

                                        by Zacks Equity Research

                                        Our intense research developed a strategy that allows investors to spend money on securities with lower risk yet with attractive returns.

                                          Why the Earnings Streak Will Continue for Aetna (AET)

                                          by Zacks Equity Research

                                          Aetna (AET) has a nice short-term history of beating earnings estimates, and looks poised to beat expectations in its next earnings report as well.

                                            LifePoint (LPNT) Thriving on Inorganic Growth, Ample Capital

                                            by Zacks Equity Research

                                            LifePoint Health Inc. (LPNT) is well poised to grow over the long term given a number of acquisitions made over the past few years.

                                              Aetna to Shift Headquarters, Aims Business Transformation

                                              by Zacks Equity Research

                                              Aetna Inc. (AET) will move out of its Hartford, to look for "younger people, technologists, innovation" as it transforms into a digital health entity.

                                                Aetna Inks New Deal to Improve Healthcare in North Carolina

                                                by Zacks Equity Research

                                                Aetna, Inc. (AET) recently inked a deal with Community Care Physician Network, LLC

                                                  Senate Releases AHCA Draft Bill, Healthcare Stocks Surge

                                                  by Zacks Equity Research

                                                  The Senate recently released the draft version of the healthcare bill that would repeal and replace the Affordable Care Act.